SCHEMBL1033987

SCHEMBL1033987

Oc1ccc(-c2ccnc(NC3CCCCC3)n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 5/20 0.56
CDK1 P06493 5/20 0.53
CCNB1 P14635 5/20 0.53
CDK2 P24941 4/20 0.53
CDK4 P11802 3/20 0.53
CCNA2 P20248 3/20 0.53
CCND1 P24385 3/20 0.53
CCNA1 P78396 3/20 0.53
MAPK10 P53779 5/20 0.53
MAPK8 P45983 3/20 0.53
MAPK9 P45984 3/20 0.53
CTSK P43235 1/20 0.52
DGAT1 O75907 1/20 0.52
CCNB2 O95067 2/20 0.51
CCNB3 Q8WWL7 2/20 0.51
GSK3B P49841 2/20 0.51
CDC7 O00311 1/20 0.51
PLK4 O00444 1/20 0.51
JAK2 O60674 1/20 0.51
MAP4K4 O95819 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1029919 0.86 IKBKB (0.57) IKBKBCDK1CCNB1CDK2CDK4
SCHEMBL1032138 0.86 IKBKB (0.76) IKBKBCDK1CCNB1CDK2CDK4
SCHEMBL1034820 0.86 CDK4 (0.57) IKBKBCDK1CCNB1CDK2CDK4
SCHEMBL1033626 0.84 CDK1 (0.53) IKBKBCDK1CCNB1CDK2CDK4
SCHEMBL1034547 0.82 EIF2AK2 (0.58) IKBKBCDK1CCNB1CDK2CDK4
SCHEMBL1033843 0.80 HDAC8 (0.56) IKBKBCDK1CCNB1CDK2CDK4
SCHEMBL1033093 0.80 IKBKB (0.52) IKBKBCDK1CCNB1CDK2CDK4
SCHEMBL3748251 0.80 PTGS2 (0.69) IKBKBCDK1CCNB1CDK2CDK4
SCHEMBL1032675 0.80 CDK1 (0.59) IKBKBCDK1CCNB1CDK2CDK4
SCHEMBL3648299 0.80 MAPK10 (0.60) IKBKBCDK1CCNB1CDK2CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed